The Best and Brightest in Biotechnology
Posted March 2nd, 2011
With our expertise in the pharmaceutical, biotech, clinical and healthcare industries, we know it’s important to keep up with the latest news in the rapidly growing biotechnology industry. The Biotech Showcase Conference, this year held in San Francisco from January 10 – 12, is the world’s largest annual healthcare investor conference.
At the conference, private and public life science companies presented some of the latest inventions and developments in the biotechnology and life science fields to investors, buyers and decision makers from the biotech, pharmaceutical, financial, legal, and consulting communities.
The conference featured representatives from more than 750 international biotechnology experts in several fields:
- Small and large molecule R&D therapeutic companies
- Platform companies
- Tool companies
- Research focused service providers
- Molecular diagnostic companies
- Personalized medicine companies
Topics on the agenda included discussions of up-to-the-minute innovations:
The Regenerative Medicine Annual State of the Industry Report covered
- the state of the cell therapy and regenerative medicine industries
- the performance of currently marketed products
- major clinical developments
- key technology advancements
- use of stem cells in drug discovery
- regulatory issues
- the current financial outlook for the sector
Proof of Relevance: The New Standard for Partnering in 2011 and Beyond focused on the importance of seeking Proof of Relevance for early stage programs and provided recent examples of strategies for achieving value inflection from demonstration of Proof of Relevance in early stage development.
Personalized Medicine, Molecular Diagnostics discussed questions such as:
- Where do we stand in terms of seeing molecular diagnostics taking a key role in determining therapeutic treatment for a patient?
- What will the regulatory scene look like?
- How about reimbursement—who will pay?
Infectious Disease: A War on Many Fronts featured representatives from a panel of companies developing our arsenal of next generation antiviral and antimicrobial weapons discussing the infectious disease landscape and their technologies and targets.
Other parts of the program focused on the practical aspects of the industry and its future:
New Drug Approval at the FDA: Is it Really as Bad as You Think It Is? A group of industry leaders demonstrated how to navigate the FDA approval process in today’s environment.
It’s Always About Money: Financing the Future featured a panel that examined the funding news of 2010 and made predictions for 2011 and how it will impact private and small-cap life science companies.
Getting Paid: Strategic Insights on Coverage and Reimbursement. This interactive workshop addressed the healthcare payment environment over the long term, how to position your product for insurance coverage and reimbursement, and gave practical tips for working with Medicare and other health payors.
Each day included an opportunity to meet one-on-one with representatives from leading companies in the private biotech, public biotech and molecular diagnostics industries.
If you need to employ highly qualified professionals in the biotech industry without incurring the liability and cost of fulltime hires, we can help! Bayside Solutions can provide the industry specialists you need and help keep your project running smoothly, profitably, and on schedule.
